Sign in to view content

Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Should Baseline Characteristics Affect Choice of Treatment?

Susan B. Bressler, MD, FASRS

Video
Published 2018

Related

Economic Benefit of Higher Durability Anti-VEGF Agents in the Treatment of Neovascular Macular Degeneration
Sabin Dang, MD
Annual Meeting Talks
2023
Confirmatory 1-Year Study Results of an Injectable Fluocinolone Acetonide Intravitreal Insert to Treat Noninfectious Posterior Segment Uveitis
Glenn J. Jaffe, MD
Annual Meeting Talks
2018
Comparative Study of Inverted ILM Flap and PRP as an Adjunct in Large Macular Holes
Naresh Babu Kannan, MS, FNB(V R),MBA (H R),FASRS,.
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more